Noticias de AUPH_US

Noticias del mercado

Últimas noticias sobre AUPH_US — 160 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AUPH_US ✕ 160 resultados
14/04/2026 AUPH_US — Stock Traders Daily
Trading Systems Reacting to (AUPH) Volatility
14/04/2026 AUPH_US — MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 12-Month High - Here's What Happened
14/04/2026 AUPH_US — The Business Journals
How activist investor Kevin Tang finally landed the Bay Area company that got away from him
14/04/2026 AUPH_US — Stock Titan
Aurinia to Acquire Kezar (NASDAQ: KZR) for $6.955 Cash plus CVR
13/04/2026 AUPH_US — Stock Titan
Aurinia to buy Kezar (KZR) for $6.955/Share plus CVR (7.39M shares)
12/04/2026 AUPH_US — MarketBeat
Ritholtz Wealth Management Acquires 174,301 Shares of Aurinia Pharmaceuticals Inc $AUPH
08/04/2026 AUPH_US — Intellectia AI
AUPH Earning Date, Earning Analysis and Earning Prediction
06/04/2026 AUPH_US — MSN ES ← EN
Transcripción de la llamada de resultados del tercer trimestre de 2025 de Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
06/04/2026 AUPH_US — MarketBeat
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of "Hold" by Analysts
06/04/2026 AUPH_US — Sahm
A Look At Aurinia Pharmaceuticals (AUPH) Valuation After Its Recent Leadership Overhaul
04/04/2026 AUPH_US — Minichart
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.96 Per Share Plus Contingent Value Rights in 2026 Merger Deal
03/04/2026 AUPH_US — Stock Traders Daily
How Aurinia Pharmaceuticals Inc (AUPH) Affects Rotational Strategy Timing
03/04/2026 AUPH_US — Stock Titan
Aurinia (NASDAQ: AUPH) to acquire Kezar with $6.955 per share cash and CVRs
03/04/2026 AUPH_US — TipRanks
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
03/04/2026 AUPH_US — TradingView
Aurinia to Acquire Kezar via $6.955-Per-Share Cash Tender Plus CVR
03/04/2026 AUPH_US — Stock Titan
Aurinia to acquire Kezar (NASDAQ: KZR) for $6.955 cash plus CVR
02/04/2026 AUPH_US — Stock Titan
Aurinia Pharmaceuticals (AUPH) COO Ryan Cole becomes SEC Form 3 insider
02/04/2026 AUPH_US — Stock Titan
Aurinia Pharmaceuticals (AUPH) CFO Michael Hearne becomes reporting insider with Form 3
01/04/2026 AUPH_US — Stock Titan
Major Kezar (KZR) shareholder signs merger support pact and drops bid
31/03/2026 AUPH_US — DirectorsTalk Interviews
Aurinia Pharmaceuticals Inc (AUPH) Investor Outlook: Exploring A 21.60% Upside Potential

Página 5 de 8

keyboard_arrow_up